Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study
The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-line antibiotic when resistance exceeds 5% in the population, ou...
Gespeichert in:
| Veröffentlicht in: | PLoS medicine 2020-04, Vol.17 (4), p.e1003077-e1003077 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e1003077 |
|---|---|
| container_issue | 4 |
| container_start_page | e1003077 |
| container_title | PLoS medicine |
| container_volume | 17 |
| creator | Yaesoubi, Reza Cohen, Ted Hsu, Katherine Gift, Thomas L Chesson, Harrell Salomon, Joshua A Grad, Yonatan H |
| description | The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-line antibiotic when resistance exceeds 5% in the population, our objective was to compare the impact of alternative strategies on the effective life spans of antibiotics and the overall burden of gonorrhea.
We developed and calibrated a mathematical model of gonorrhea transmission among men who have sex with men (MSM) in the United States. We calibrated the model to the estimated prevalence of gonorrhea, the rate of gonorrhea cases, and the proportion of cases presenting symptoms among MSM in the US. We used this model to project the effective life span of antibiotics and the number of gonorrhea cases expected under current and alternative surveillance strategies over a 50-year simulation period. We demonstrate that compared to the current practice, a strategy that uses quarterly (as opposed to yearly) surveillance estimates and incorporates both the estimated prevalence of resistance and the trend in the prevalence of resistance to determine treatment guidelines could extend the effective life span of antibiotics by 0.83 years. This is equivalent to successfully treating an additional 80.1 (95% uncertainty interval: [47.7, 111.9]) gonorrhea cases per 100,000 MSM population each year with the first-line antibiotics without worsening the burden of gonorrhea. If the annual number of isolates tested for drug susceptibility is doubled, this strategy could increase the effective life span of antibiotics by 0.94 years, which is equivalent to successfully treating an additional 91.1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing the incidence of gonorrhea. Study limitations include that our conclusions might not be generalizable to other settings because our model describes the transmission of gonorrhea among the US MSM population, and, to better capture uncertainty in the characteristics of current and future antibiotics, we chose to model hypothetical drugs with characteristics similar to the antibiotics commonly used in gonorrhea treatment.
Our results suggest that use of data from surveillance programs could be expanded to prolong the clinical effectiveness of antibiotics without increasing the burden of the disease. This highlights the importance of maintaining effective surveillance sys |
| doi_str_mv | 10.1371/journal.pmed.1003077 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2451546124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_37ce22f6525b4fe78ec35c58da0f7428</doaj_id><sourcerecordid>2451546124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-38c480dc8036348e879b0d8109709999fd866d581bb3c2195ab2d464a9eb401e3</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIloV_gMASFy67-CuxwwGpqvioVIkD9Gw59iTxKokX22npT-Pf4c1uqxbhg23NvPc88zxF8ZrgDWGCfNj6OUx62OxGsBuCMcNCPClOScnrNalE9fTB_aR4EeMWY1rjGj8vThilnHHOTos_Z1bvkrsG1M3OwuAmiKj1AaUeUAqg0whTQr5FnZ98CD1olDxyk8m5CAsM2hbMojG4FlDc6WlP0FNyjfPJmYj06KcOZSl003vU64yN8BvduNQvUTctSleTS2DRj6QTxI_oDI06h_PmjB7Q6JcCOxTTbG9fFs9aPUR4dTxXxdWXzz_Pv60vv3-9OD-7XJuSVmnNpOESWyMxqxiXIEXdYCsJrgWu82qtrCpbStI0zFBSl7qhlldc19BwTICtircH3d3gozq6HhXlZba3ItnIVXFxQFivt2oX3KjDrfLaqSXgQ6d0yC0MoJgwQGlblbRseAtCgmGlKaXVuBWcyqz16fja3OSPNdn8oIdHoo8zk-tV56-VIJRWNcsC748Cwf-aISY1umhgGPQEfs51M1lRKSohMvTdP9D_d8cPKBN8jAHa-2IIVvtJvGOp_SSq4yRm2puHjdyT7kaP_QUXG98k</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2451546124</pqid></control><display><type>article</type><title>Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yaesoubi, Reza ; Cohen, Ted ; Hsu, Katherine ; Gift, Thomas L ; Chesson, Harrell ; Salomon, Joshua A ; Grad, Yonatan H</creator><contributor>Low, Nicola</contributor><creatorcontrib>Yaesoubi, Reza ; Cohen, Ted ; Hsu, Katherine ; Gift, Thomas L ; Chesson, Harrell ; Salomon, Joshua A ; Grad, Yonatan H ; Low, Nicola</creatorcontrib><description>The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-line antibiotic when resistance exceeds 5% in the population, our objective was to compare the impact of alternative strategies on the effective life spans of antibiotics and the overall burden of gonorrhea.
We developed and calibrated a mathematical model of gonorrhea transmission among men who have sex with men (MSM) in the United States. We calibrated the model to the estimated prevalence of gonorrhea, the rate of gonorrhea cases, and the proportion of cases presenting symptoms among MSM in the US. We used this model to project the effective life span of antibiotics and the number of gonorrhea cases expected under current and alternative surveillance strategies over a 50-year simulation period. We demonstrate that compared to the current practice, a strategy that uses quarterly (as opposed to yearly) surveillance estimates and incorporates both the estimated prevalence of resistance and the trend in the prevalence of resistance to determine treatment guidelines could extend the effective life span of antibiotics by 0.83 years. This is equivalent to successfully treating an additional 80.1 (95% uncertainty interval: [47.7, 111.9]) gonorrhea cases per 100,000 MSM population each year with the first-line antibiotics without worsening the burden of gonorrhea. If the annual number of isolates tested for drug susceptibility is doubled, this strategy could increase the effective life span of antibiotics by 0.94 years, which is equivalent to successfully treating an additional 91.1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing the incidence of gonorrhea. Study limitations include that our conclusions might not be generalizable to other settings because our model describes the transmission of gonorrhea among the US MSM population, and, to better capture uncertainty in the characteristics of current and future antibiotics, we chose to model hypothetical drugs with characteristics similar to the antibiotics commonly used in gonorrhea treatment.
Our results suggest that use of data from surveillance programs could be expanded to prolong the clinical effectiveness of antibiotics without increasing the burden of the disease. This highlights the importance of maintaining effective surveillance systems and the engagement of policy makers to turn surveillance findings into timely and effective decisions.</description><identifier>ISSN: 1549-1676</identifier><identifier>ISSN: 1549-1277</identifier><identifier>EISSN: 1549-1676</identifier><identifier>DOI: 10.1371/journal.pmed.1003077</identifier><identifier>PMID: 32243443</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Antibiotics ; Antimicrobial agents ; Antimicrobial resistance ; Biology and Life Sciences ; Disease control ; Drugs ; Estimates ; Gonorrhea ; Health surveillance ; Infections ; Life span ; Mathematical models ; Medicine and Health Sciences ; People and Places ; Prevention ; Public health ; Supervision ; Trends</subject><ispartof>PLoS medicine, 2020-04, Vol.17 (4), p.e1003077-e1003077</ispartof><rights>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-38c480dc8036348e879b0d8109709999fd866d581bb3c2195ab2d464a9eb401e3</citedby><cites>FETCH-LOGICAL-c526t-38c480dc8036348e879b0d8109709999fd866d581bb3c2195ab2d464a9eb401e3</cites><orcidid>0000-0003-3929-5515 ; 0000-0001-5646-1314 ; 0000-0002-8091-7198 ; 0000-0002-9276-5750 ; 0000-0001-7713-4267</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122693/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122693/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32243443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Low, Nicola</contributor><creatorcontrib>Yaesoubi, Reza</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Hsu, Katherine</creatorcontrib><creatorcontrib>Gift, Thomas L</creatorcontrib><creatorcontrib>Chesson, Harrell</creatorcontrib><creatorcontrib>Salomon, Joshua A</creatorcontrib><creatorcontrib>Grad, Yonatan H</creatorcontrib><title>Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study</title><title>PLoS medicine</title><addtitle>PLoS Med</addtitle><description>The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-line antibiotic when resistance exceeds 5% in the population, our objective was to compare the impact of alternative strategies on the effective life spans of antibiotics and the overall burden of gonorrhea.
We developed and calibrated a mathematical model of gonorrhea transmission among men who have sex with men (MSM) in the United States. We calibrated the model to the estimated prevalence of gonorrhea, the rate of gonorrhea cases, and the proportion of cases presenting symptoms among MSM in the US. We used this model to project the effective life span of antibiotics and the number of gonorrhea cases expected under current and alternative surveillance strategies over a 50-year simulation period. We demonstrate that compared to the current practice, a strategy that uses quarterly (as opposed to yearly) surveillance estimates and incorporates both the estimated prevalence of resistance and the trend in the prevalence of resistance to determine treatment guidelines could extend the effective life span of antibiotics by 0.83 years. This is equivalent to successfully treating an additional 80.1 (95% uncertainty interval: [47.7, 111.9]) gonorrhea cases per 100,000 MSM population each year with the first-line antibiotics without worsening the burden of gonorrhea. If the annual number of isolates tested for drug susceptibility is doubled, this strategy could increase the effective life span of antibiotics by 0.94 years, which is equivalent to successfully treating an additional 91.1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing the incidence of gonorrhea. Study limitations include that our conclusions might not be generalizable to other settings because our model describes the transmission of gonorrhea among the US MSM population, and, to better capture uncertainty in the characteristics of current and future antibiotics, we chose to model hypothetical drugs with characteristics similar to the antibiotics commonly used in gonorrhea treatment.
Our results suggest that use of data from surveillance programs could be expanded to prolong the clinical effectiveness of antibiotics without increasing the burden of the disease. This highlights the importance of maintaining effective surveillance systems and the engagement of policy makers to turn surveillance findings into timely and effective decisions.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Biology and Life Sciences</subject><subject>Disease control</subject><subject>Drugs</subject><subject>Estimates</subject><subject>Gonorrhea</subject><subject>Health surveillance</subject><subject>Infections</subject><subject>Life span</subject><subject>Mathematical models</subject><subject>Medicine and Health Sciences</subject><subject>People and Places</subject><subject>Prevention</subject><subject>Public health</subject><subject>Supervision</subject><subject>Trends</subject><issn>1549-1676</issn><issn>1549-1277</issn><issn>1549-1676</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIloV_gMASFy67-CuxwwGpqvioVIkD9Gw59iTxKokX22npT-Pf4c1uqxbhg23NvPc88zxF8ZrgDWGCfNj6OUx62OxGsBuCMcNCPClOScnrNalE9fTB_aR4EeMWY1rjGj8vThilnHHOTos_Z1bvkrsG1M3OwuAmiKj1AaUeUAqg0whTQr5FnZ98CD1olDxyk8m5CAsM2hbMojG4FlDc6WlP0FNyjfPJmYj06KcOZSl003vU64yN8BvduNQvUTctSleTS2DRj6QTxI_oDI06h_PmjB7Q6JcCOxTTbG9fFs9aPUR4dTxXxdWXzz_Pv60vv3-9OD-7XJuSVmnNpOESWyMxqxiXIEXdYCsJrgWu82qtrCpbStI0zFBSl7qhlldc19BwTICtircH3d3gozq6HhXlZba3ItnIVXFxQFivt2oX3KjDrfLaqSXgQ6d0yC0MoJgwQGlblbRseAtCgmGlKaXVuBWcyqz16fja3OSPNdn8oIdHoo8zk-tV56-VIJRWNcsC748Cwf-aISY1umhgGPQEfs51M1lRKSohMvTdP9D_d8cPKBN8jAHa-2IIVvtJvGOp_SSq4yRm2puHjdyT7kaP_QUXG98k</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Yaesoubi, Reza</creator><creator>Cohen, Ted</creator><creator>Hsu, Katherine</creator><creator>Gift, Thomas L</creator><creator>Chesson, Harrell</creator><creator>Salomon, Joshua A</creator><creator>Grad, Yonatan H</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><scope>CZK</scope><orcidid>https://orcid.org/0000-0003-3929-5515</orcidid><orcidid>https://orcid.org/0000-0001-5646-1314</orcidid><orcidid>https://orcid.org/0000-0002-8091-7198</orcidid><orcidid>https://orcid.org/0000-0002-9276-5750</orcidid><orcidid>https://orcid.org/0000-0001-7713-4267</orcidid></search><sort><creationdate>20200401</creationdate><title>Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study</title><author>Yaesoubi, Reza ; Cohen, Ted ; Hsu, Katherine ; Gift, Thomas L ; Chesson, Harrell ; Salomon, Joshua A ; Grad, Yonatan H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-38c480dc8036348e879b0d8109709999fd866d581bb3c2195ab2d464a9eb401e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Biology and Life Sciences</topic><topic>Disease control</topic><topic>Drugs</topic><topic>Estimates</topic><topic>Gonorrhea</topic><topic>Health surveillance</topic><topic>Infections</topic><topic>Life span</topic><topic>Mathematical models</topic><topic>Medicine and Health Sciences</topic><topic>People and Places</topic><topic>Prevention</topic><topic>Public health</topic><topic>Supervision</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yaesoubi, Reza</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Hsu, Katherine</creatorcontrib><creatorcontrib>Gift, Thomas L</creatorcontrib><creatorcontrib>Chesson, Harrell</creatorcontrib><creatorcontrib>Salomon, Joshua A</creatorcontrib><creatorcontrib>Grad, Yonatan H</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><collection>PLoS Medicine</collection><jtitle>PLoS medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yaesoubi, Reza</au><au>Cohen, Ted</au><au>Hsu, Katherine</au><au>Gift, Thomas L</au><au>Chesson, Harrell</au><au>Salomon, Joshua A</au><au>Grad, Yonatan H</au><au>Low, Nicola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study</atitle><jtitle>PLoS medicine</jtitle><addtitle>PLoS Med</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>17</volume><issue>4</issue><spage>e1003077</spage><epage>e1003077</epage><pages>e1003077-e1003077</pages><issn>1549-1676</issn><issn>1549-1277</issn><eissn>1549-1676</eissn><abstract>The rise of gonococcal antimicrobial resistance highlights the need for strategies that extend the clinically useful life span of antibiotics. Because there is limited evidence to support the current practice of switching empiric first-line antibiotic when resistance exceeds 5% in the population, our objective was to compare the impact of alternative strategies on the effective life spans of antibiotics and the overall burden of gonorrhea.
We developed and calibrated a mathematical model of gonorrhea transmission among men who have sex with men (MSM) in the United States. We calibrated the model to the estimated prevalence of gonorrhea, the rate of gonorrhea cases, and the proportion of cases presenting symptoms among MSM in the US. We used this model to project the effective life span of antibiotics and the number of gonorrhea cases expected under current and alternative surveillance strategies over a 50-year simulation period. We demonstrate that compared to the current practice, a strategy that uses quarterly (as opposed to yearly) surveillance estimates and incorporates both the estimated prevalence of resistance and the trend in the prevalence of resistance to determine treatment guidelines could extend the effective life span of antibiotics by 0.83 years. This is equivalent to successfully treating an additional 80.1 (95% uncertainty interval: [47.7, 111.9]) gonorrhea cases per 100,000 MSM population each year with the first-line antibiotics without worsening the burden of gonorrhea. If the annual number of isolates tested for drug susceptibility is doubled, this strategy could increase the effective life span of antibiotics by 0.94 years, which is equivalent to successfully treating an additional 91.1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing the incidence of gonorrhea. Study limitations include that our conclusions might not be generalizable to other settings because our model describes the transmission of gonorrhea among the US MSM population, and, to better capture uncertainty in the characteristics of current and future antibiotics, we chose to model hypothetical drugs with characteristics similar to the antibiotics commonly used in gonorrhea treatment.
Our results suggest that use of data from surveillance programs could be expanded to prolong the clinical effectiveness of antibiotics without increasing the burden of the disease. This highlights the importance of maintaining effective surveillance systems and the engagement of policy makers to turn surveillance findings into timely and effective decisions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32243443</pmid><doi>10.1371/journal.pmed.1003077</doi><orcidid>https://orcid.org/0000-0003-3929-5515</orcidid><orcidid>https://orcid.org/0000-0001-5646-1314</orcidid><orcidid>https://orcid.org/0000-0002-8091-7198</orcidid><orcidid>https://orcid.org/0000-0002-9276-5750</orcidid><orcidid>https://orcid.org/0000-0001-7713-4267</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1549-1676 |
| ispartof | PLoS medicine, 2020-04, Vol.17 (4), p.e1003077-e1003077 |
| issn | 1549-1676 1549-1277 1549-1676 |
| language | eng |
| recordid | cdi_plos_journals_2451546124 |
| source | DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Antibiotics Antimicrobial agents Antimicrobial resistance Biology and Life Sciences Disease control Drugs Estimates Gonorrhea Health surveillance Infections Life span Mathematical models Medicine and Health Sciences People and Places Prevention Public health Supervision Trends |
| title | Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adaptive%20guidelines%20for%20the%20treatment%20of%20gonorrhea%20to%20increase%20the%20effective%20life%20span%20of%20antibiotics%20among%20men%20who%20have%20sex%20with%20men%20in%20the%20United%20States:%20A%20mathematical%20modeling%20study&rft.jtitle=PLoS%20medicine&rft.au=Yaesoubi,%20Reza&rft.date=2020-04-01&rft.volume=17&rft.issue=4&rft.spage=e1003077&rft.epage=e1003077&rft.pages=e1003077-e1003077&rft.issn=1549-1676&rft.eissn=1549-1676&rft_id=info:doi/10.1371/journal.pmed.1003077&rft_dat=%3Cproquest_plos_%3E2451546124%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2451546124&rft_id=info:pmid/32243443&rft_doaj_id=oai_doaj_org_article_37ce22f6525b4fe78ec35c58da0f7428&rfr_iscdi=true |